Search

everythinglearnresearchcommunity

for

Search:↓

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Both surgical hairline advancement and follicular unit transplantation effectively lower the female hairline, but they differ in speed, scarring, and naturalness of results.

Immune activities and specific genes are important in male pattern baldness.

Scaffoldin helps form hard skin structures in chicken embryos.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

People with Down syndrome are more likely to have alopecia areata and need regular skin check-ups.

Most skin conditions in Down syndrome are benign and involve dry or thickened skin.

Anatolian native goat down-hair is similar to cashmere and can be used for high-quality textiles.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Tempeh oil rich in linoleic acid may protect against skin aging caused by UV light.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Plant roots respond to fungus smells by possibly using certain proteins and a plant hormone to change root growth, but more research is needed.

People with Down's syndrome are more likely to have syringomas.

People with Down syndrome are more likely to experience hair loss, and using dermoscopy can help diagnose it.

Changing the amount of PLC5 in Arabidopsis affects root growth and drought resistance, with less PLC5 slowing root growth and more PLC5 improving drought tolerance but hindering root hair growth.

Hairless protein reduces Msx2 gene activity, affecting hair follicle development.

Testosterone reduces key molecules needed for early pregnancy in rats.

The document concludes that pig iPSCs show promise for transplant therapies and the field is advancing in controlling cell behavior for biology and medicine.

Cholecystokinin may help reduce skin inflammation in psoriasis.

People with Down's syndrome often have more skin problems due to a weak immune system.

Loss of Msx2 function causes eye development issues similar to Peters anomaly.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.